Vulvar cancer

Vulvar cancer overview

If you have vulvar cancer, your outcomes will be better if you are treated by a gynecologic oncologist right from the beginning.

Seattle Cancer Care Alliance has more gynecologic oncologists than any other medical center or clinic in the Pacific Northwest. They treat all types of gynecologic cancer, including cervical, endometrial, ovarian, and vulvar cancers, as well as uterine sarcoma and gestational trophoblastic disease.

Request an appointment

fax (206) 598-3590
For referring providers, you may fax the referral to us.

Where you're treated first matters most

The most important decision a person with cancer will make is deciding where to get treated. Studies have shown that patients who begin their treatment at a top regional cancer center, like Seattle Cancer Care Alliance (SCCA), have better outcomes than those who start their treatment elsewhere. And here’s why:

  • Expert care: SCCA doctors treat only cancer and specialize in specific cancer types, such as gynecologic cancer. They have a deep understanding of their specialty since they diagnose and treat thousands of cancer cases every year. This experience builds their expertise that makes better outcomes possible.
  • Newest treatments: Doctors at SCCA have access to all the latest developments and research in treating cancer. Your care comes from combined expertise of Fred Hutchinson Cancer Research Center, UW Medicine, and Seattle Children's. 

When your treatment is complete, we'll keep close watch on your health through our Women’s Wellness Clinic where we provide wellness-focused follow-up care  focused on cancer treatment recovery.

Where you will be seen

Women who have received a diagnosis of vulvar cancer will be seen initially at the University of Washington Medical Center. In some cases, treatments will also be scheduled at SCCA. If surgery is required, surgical procedures are performed at UW Medical Center, where you may also have follow-up and/or chemotherapy/radiation treatments, if necessary. Your doctor or patient care coordinator will clarify the location where you will receive your care.

Follow-up after treatment

At SCCA, we follow our patients for as long as they choose. Typically, you will come for checkups every three months for the first two years after your treatment for vulvar cancer. When women live far away from Seattle, we try to coordinate followup care if possible and desirable with your local gynecolgist. 

Women who reach the two-year mark without a recurrence of their disease are less likely to ever have a recurrence. From that point, we usually ask you to come in every six months for a checkup until five years have passed.

After five years, a once-a-year checkup is all that is recommended.

Our patients say that they find it reassuring to see the same doctors who treated them--experts in gynecologic cancers--for their follow-up visits.


Vulvar cancer is cancer of the external female sexual organs. Most often, it is a type of skin cancer. It is a fairly rare disease, affecting only about one-half of one percent of all American women who are diagnosed with cancer each year. If detected early, before it has spread to the lymph nodes, the chances of a cure are quite high, 90 percent or better.

Remember, each woman's cancer is different, as are her circumstances, preferences, and beliefs. A treatment that works well for another woman may not be right for you.


At SCCA, you receive care from a team of providers with extensive experience in your disease. Your team includes doctors, a team coordinator, a registered nurse, an advanced practice provider and others, based on your needs. You also have access to experts like nutritionists, social workers, acupuncturists, psychiatrists and more who specialize in supporting people with cancer or blood disorders.

Clinical trials

SCCA was formed, in part, to bring promising new treatments to patients faster. For vulvar cancer patients, this means more treatment options at SCCA than you might find elsewhere, including the chance to participate in one of many ongoing clinical trials conducted at SCCA and its partner organizations, Fred Hutch and UW Medicine.